Sandip Patel, MD and Narjust Duma, MD discuss a case scenario of a 45-year-old Hispanic female with lung adenocarcinoma.
Clinical
In a webcast discussion, Pharmacy Times interviewed a panel of experts on the future of psychedelic medicine and the role of the pharmacy in that future. Specifically, the experts discuss psychedelic medicine access and what would different distribution models could look like to provide the best access points for patients. Additionally, the experts touch on who they think should be authorized to either administer or obtain psychedelic medicine and if the administration of psychedelic drugs should only be in the hands of certain health care professionals, such as psychiatrists.
Arjun Srinivasan, MD, is the Associate Director for Healthcare Associated Prevention Programs, Division of Healthcare Quality Promotion at the Centers for Disease Control and Prevention. One of Doctor Srinivasan’s concerns is the growing threat posed by pathogens that are becoming immune to antibiotics. In the interview, he talks about ways the government might try to encourage pharmaceutical companies to develop new, more effective antibiotics.
Author of the “Chasing the Widowmaker: The History of the Heart Attack Pandemic,” Dr. Meshkov leveraged his 40 years of experience studying and practicing cardiology as the basis of his book, which he hopes provides a comprehensive overview. In this segment, Meshkov, who serves on the editorial advisory board for Practical Cardiology, discusses his foray into authorship as well as the challenges he faced as a first-time author.
Robert Popovian, PharmD, MS, chief science policy officer at Global Healthy Living Foundation, and Bret Jackson, president of the Economic Alliance for Michigan, join Behind the Science to discuss the strength of multiple policy initiatives that have been tested at the federal and state level to get biosimilars into the hands of patients who need them.
Drug development via a pathway approach creates the potential to treat multiple diseases with a single therapy. Alyssa Johnsen, MD, PhD, joins Deep Dive to discuss how the ongoing research by Janssen Immunology continues to confirm their IL-pathway model to treating immune mediated diseases.
Noting the historic implications of the COVID-19 virus, Dr. Jonathan Silverberg has weathered the pandemic by providing patients with care through a hybrid system of telehealth and in-person visits. He notes the changes in the healthcare system as well as the resilience of patients and physicians alike.
Asteres® chairman and BioIQ CEO, Sean Slovenski joined Inside the Practice to discuss 24/7 automated pharmacy pickup. ScriptCenter allows your pharmacy staff to maintain control of filling and checking prescriptions, while ScriptCenter takes care of the secure storage, tracking, pickup, and payment of your pharmacist-filled prescriptions. Asteres® develops ScriptCenter kiosks and lockers for secure and safe pickup of prescriptions and healthcare products.
Jonathan Ogurchak, PharmD, CSP, sat down with Natasha Khrystolubova, BPharm, BCOP, to discuss the need for a better structure for medical data and ways that this data can be linked throughout the continuum of care. In the discussion, Ogurchak and Khrysolubova discussed questions around HIPAA compliance, accessibility, ethics, and privacy. They agreed that there is a massive amount of patient data thanks to trackers and wearable devices, but allowing all of those data sources to align with the health care system is a major priority to improve patient care.
A panel of oncologists join Behind the Science to review the data and discuss the impact of 4 recent FDA approvals in oncology.
Dr. Rexford Ahima discusses pediatric obesity in the United States and how the pandemic has affected it.
Physicians experience the highest rates of burnout among professionals, and this has only gotten worse during the pandemic. H. Steven Moffic, MD, shares some suggestions for dealing with burnout.
Phillip Low, PhD, Presidential Scholar for Drug Discovery and Ralph C. Corley Distinguished Professor of Chemistry-Biochemistry from Purdue University joined Inside the Practice to discuss the creation and approval of pafolacianine. This agent was approved in November 2021 to be utilized during surgery to identify malignant ovarian lesions. In the interview, Low discusses how the idea came to be, implementing this as a standard of practice, and the potential to utilize this agent for other cancers.
Linda Dickey, RN, MPH, CIC, CPHQ, FAPIC, is the new president of the Association for Professionals in Infection Control and Epidemiology—APIC. She talks about what it takes to become an infection preventionist, and the challenges the infection preventionist field faces. For instance. APIC is pushing to have states mandate that anybody working with the title infection preventionist be certified as such, and that nursing homes must have a full-time IP on staff.
Dr. Keipp Talbot discussed with us the currently increasing rate of influenza in the US, as well as the state of research into flu vaccination—a topic which has significant scrutiny right now given the efficacy of COVID-19 vaccines. Among those options for advancing flu vaccines were products designed for older and/or immunocompromised patients, as well as mRNA technology. Additionally, she discussed how, contrary to common belief, flu research may be better informed by sequencing and screening strategies implemented by COVID-19 response—not the other way around.
Dr. Lauren Natbony and Dr. Deena Kuruvilla join Second Opinion to offer a look ahead into heachache medicine in 2022, including what things look like currently, what still needs to be addressed, and what's to come in the future.
Rodrigo Cerdá, M.D., M.P.H., who was recently promoted to the position of executive vice president of health services and chief medical officer of Independence Blue Cross (IBX), discusses the role of medical director at IBX and how the medical review functions at the company are organized. Wehrwein and Cerdá also discussed prior authorization and how IBX is addressing social determinant of health and health equity issues.
Several doctors speak about their biggest takeaways and the most important abstracts presented at the 2021 ASH Annual Meeting and Exposition.
Antimicrobial resistance is a paramount concern in medicine. And as it can take many years to develop new antibiotics, alternative therapies are being considered. For example, bacteriophage is a therapeutic platform being used internationally and is emerging her in the United States. Locus Biosciences CEO Paul Garofolo provides an overview of bacteriophage and its potential therapeutic applications.
On this episode we look at the challenges dentists face when communicating with both patients and other health care providers about periodontal disease. While it can go largely unnoticed in undiagnosed patients, periodontitis is among the most widespread infectious diseases around the globe and numerous studies link periodontal issues to other conditions including diabetes and heart disease. Yet patients rarely understand the full gravity of the condition and often refuse treatment. Additionally, medical doctors rarely refer diabetic patients or others with periodontal comorbidities to a dental professional for a periodontal evaluation. Dr. Richard Nagelberg, a full time practicing dentist and director of medical affairs for OraPharma, is hopeful that a new free tool created by OraPharma can be used to both improve periodontal diagnostics as well as patient understanding of the condition and communication about the disease with other health care professionals. Dr Nagelberg joins Dental Products Report editorial director Noah Levine to talk about the challenges presented by periodontal disease and how using the MyPerioHealth app with a patient can help.
Based on a presentation she gave at the 2021 American Society for Reproductive Medicine (ASRM)’s Annual Meeting, Dr. Alice Domar outlines the importance of mental health for patients with pregnancy loss. Get Dr. Domar’s advice on what not to say to patients, when the right time may be to discuss treatment options/counseling services, and how to be emotionally considerate toward patients throughout the process.
Following published research around the impact of the COVID-19 pandemic on the professional and personal lives oncologists, Dr. Ajeet Garja, chief medical officer of Cardinal Health, discusses his experience and the study findings.
Tony Makarich, PharmD and vice president of clinical services at Catalyst Health Rx, joined to discuss the benefits for health care providers of a relationship and team-based pharmacy model. He dives into Catalyst Health Rx's current pharmacy model that values relationships with convenience for medication home delivery and assures that providers do not lose sight of the impact they have on their patients.
Gary Linkov, MD, board-certified facial, plastic and hair surgeon and founder and medical director of City Facial Plastics in New York, New York highlights the world of hair loss. He describes not only how to treat and prevent the condition, but how his own experience with hair loss helps him treat patients.
A panel of urologists share the biggest takeaways from SUO 2021.
Pat A. Basu, MD, MBA, President and Chief Executive Officer of Cancer Treatment Centers of America, discusses the shadow curve caused by the COVID-19 pandemic, and other disparities in cancer care.
With 2022 bringing a new chapter for cancer research, many physicians and researchers are looking forward to new developments in the coming year. CURE asked several of them to share what they’re excited about or hoping to see in 2022.
The pandemic has brought on a new era of flexible work in healthcare, as providers now utilize telehealth technology in their day to day. For Dr. Elizabeth Hawk, a radiologist and single mother, more flexible work arrangements can be incredibly beneficial, but for women in radiology, a more flexible work environment may also have its drawbacks. In this episode of Deep Dive, Dr. Hawk expands on the pros and cons of flexible work environments and the implications it may have on women in radiology.
Edith P. Mitchell, MD, MACP, FCPP, FRCS, explains her work to improve disparities among different population groups for better equality in access to cancer testing and treatment.
After a year of controversy and conversation in Alzheimer disease that saw the first approval for the field in 2 decades, Dr. Anton Porsteinsson shared his perspective on the progress made and commented on the agents moving through the pipeline and the state of things heading into 2022.
